Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer
JAAD International
· Elsevier
Аннотация
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kentaro Ito, Nobuyuki Yamamoto, Daichi Fujimoto, Hiroaki Akamatsu, Yuichi Ozawa, Takehito Shukuya, Hidetoshi Hayashi, Koji Yamamoto, Toshio Shimokawa, Hirotsugu Kenmotsu, Junichi Shimizu, Takayasu Kurata, Motohiro Tamiya, Yukio Hosomi, Jun Sugisaka, Yuka Kato, Hideki Terai, Satoshi Ikeda, Haruko Daga, Kenichi Koyama
Читать у издателя →
Цитирование
Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000550?dgcid=rss_sd_all
Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer. JAAD International. https://www.sciencedirect.com/science/article/pii/S3117504X26000550?dgcid=rss_sd_all
“Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer.” JAAD International.
@article{article5808,
title = {Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000550?dgcid=rss_sd_all}
}